| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Operating Officer
2 companies
Palczuk Linda is a Director at AVADEL PHARMACEUTICALS PLC with holdings across 2 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $68K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 5,000 | $7.93 | $39,640.00 | +7.9% | +0.8% | +172.3% | |
| Dec 6, 2024 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 3,000 | $10.19 | $30,567.60 | +4.7% | -21.2% | +113.4% | |
| May 9, 2023 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 2,500 | $14.76 | $36,900.00 | +5.0% | -11.0% | +8.0% | |
| Dec 23, 2022 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 2,000 | $7.20 | $14,405.00 | +4.2% | +30.9% | +97.7% | |
| May 27, 2022 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 10,000 | $1.60 | $16,000.00 | +26.4% | +182.0% | +453.6% | |
| Aug 14, 2020 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 2,500 | $7.94 | $19,849.75 | +7.1% | - | - | |
| Dec 3, 2019 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 7,500 | $5.91 | $44,325.00 | +26.9% | - | - | |
| Jan 16, 2019 | VRCA Verrica Pharmaceuticals Inc. | Chief Operating Officer | Buy | 3,000 | $10.53 | $31,590.00 | +54.5% | - | - | |
| Sep 17, 2018 | VRCA Verrica Pharmaceuticals Inc. | Chief Operating Officer | Buy | 2,500 | $16.52 | $41,300.00 | +83.3% | - | - | |
| Jun 19, 2018 | VRCA Verrica Pharmaceuticals Inc. | Chief Operating Officer | Buy | 3,000 | $15.00 | $45,000.00 | New | - | - |